Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07341815Not ApplicableRecruiting

Parental Support Intervention in an Advanced Oncological Context

Role: collaborator

NCT07236021Not ApplicableRecruiting

e-Motion : Promoting Emotion Regulation in Chronic Cancer

Role: collaborator

NCT03905278Not ApplicableCompleted

Parental Support Intervention in the Oncological Context

Role: collaborator

NCT03336827Not ApplicableCompleted

Improving Emotion Regulation at the End of Breast Cancer Treatment

Role: collaborator

NCT02836197Not ApplicableUnknown

Randomized Controlled Trial Assessing the Efficacy of a Communication Skills Training Program

Role: collaborator

All 5 trials loaded